KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Prepaid Assets (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Prepaid Assets for 8 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 3.72% to $8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Dec 2025, up 3.72% year-over-year, with the annual reading at $8.0 million for FY2025, 3.72% up from the prior year.
  • Prepaid Assets hit $8.0 million in Q4 2025 for Castle Biosciences, down from $11.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $12.1 million in Q2 2025 to a low of $3.1 million in Q1 2021.
  • Historically, Prepaid Assets has averaged $6.9 million across 5 years, with a median of $6.5 million in 2023.
  • Biggest five-year swings in Prepaid Assets: surged 99.13% in 2021 and later dropped 8.47% in 2024.
  • Year by year, Prepaid Assets stood at $4.8 million in 2021, then rose by 29.12% to $6.2 million in 2022, then increased by 1.37% to $6.3 million in 2023, then rose by 21.92% to $7.7 million in 2024, then increased by 3.72% to $8.0 million in 2025.
  • Business Quant data shows Prepaid Assets for CSTL at $8.0 million in Q4 2025, $11.9 million in Q3 2025, and $12.1 million in Q2 2025.